Back to results
US 10,953,052 B2Granted
Modifying bacteriophage
AssigneePhico Therapeutics Ltd.
InventorsHeather Fairhead, Adam Wilkinson, Anne Barnard, Emmanuele Severi, Neil Anderson, Katy Pitts
Life of this patent
Estimating the term…
Abstract
A method for modifying the genome of a lytic target phage, uses of the method and products thereof are described. Compositions comprising such phage are also described. The compositions may be formulated as a medicament, which are useful for human treatment and may treat various conditions, including bacterial infections.
Claims21
A method for modifying the genome of a lytic target phage, wherein the target phage genome includes a first target sequence and a second target sequence, which method comprises:
- (a) providing a vector which contains a phage-targeting region comprising a host range determinant of a marker phage, different from the host range determinant of the target phage, wherein the phage-targeting region is flanked by first and second flanking sequences homologous to the first and second target sequences of the target phage genome, and wherein the phage-targeting region of the vector further comprises an exogenous DNA sequence for incorporation into the genome of the target phage;
- (b) introducing the vector into a first host cell, which host cell is a host for the target phage;
- (c) infecting the first host cell with the target phage;
- (d) allowing replication of the phage and recombination between the target phage genome and vector to take place whereby the genome of the target phage is modified;
- (e) propagating resultant phage on a second host cell, which host cell is a host for the marker phage and not the target phage, wherein said propagating indicates that said resultant phage comprise said exogenous DNA sequence;
- and
- (f) harvesting the resultant phage.
4 more elements
Dependencies are inferred from the claim text.